RGC logo

Regencell Bioscience Holdings Limited (RGC) Cash From Investing

Annual CFI

$5.24 M
+$5.18 M+8785.76%

01 June 2024

RGC Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGC Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8785.8%--
3 y3 years+100.0%--
5 y5 years+100.0%--

RGC Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+148.6%
5 y5 yearsat high+148.6%
alltimeall timeat high+148.6%

Regencell Bioscience Holdings Limited Cash From Investing History

DateAnnualQuarterlyTTM
June 2024
$5.24 M(+8785.8%)
-
-
June 2023
$59.00 K(-100.5%)
-
-
June 2022
-$10.78 M(<-9900.0%)
-
-
DateAnnualQuarterlyTTM
June 2021
$0.00(-100.0%)
-
-
June 2020
-$117.80 K(<-9900.0%)
-
-
June 2019
$0.00
-
-

FAQ

  • What is Regencell Bioscience Holdings Limited annual cash flow from investing activities?
  • What is the all time high annual CFI for Regencell Bioscience Holdings Limited?
  • What is Regencell Bioscience Holdings Limited annual CFI year-on-year change?

What is Regencell Bioscience Holdings Limited annual cash flow from investing activities?

The current annual CFI of RGC is $5.24 M

What is the all time high annual CFI for Regencell Bioscience Holdings Limited?

Regencell Bioscience Holdings Limited all-time high annual cash flow from investing activities is $5.24 M

What is Regencell Bioscience Holdings Limited annual CFI year-on-year change?

Over the past year, RGC annual cash flow from investing activities has changed by +$5.18 M (+8785.76%)